Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
First Trust NYSE Arca Biotechnology Index Fund (NY: FBT)
59.41 USD  -0.25 (-0.42%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News
Fund Overview
First Trust NYSE Arca Biotechnology Index Fund
Sector
Exchange Traded NY
Net Assets 347.55M
Inception Date
Related Funds MVT PINR ZUE TMC
Quote
Price 59.41
Volume 33,236
Last Trade May 20, 6:40pm
Change (%)
-0.25 (-0.42%)
Prev. Close 59.66
YTD %
+29.29%
Dividend Yield 0.45%
Performance
YTD
+13.46 (29.29%)
1 Month
+5.54 (10.28%)
3 Month
+9.21 (18.34%)
6 Month
+15.72 (35.98%)
1 Year
+16.97 (39.99%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
ETFs to Watch May 20, 2013 (GDX, HAO, XME)
Today 6:27 EDT
Here is the ETF Professor's ETF Watch List for Monday, May 20, 2013. Metals plays: Market Vectors Gold Miners ETF (NYSE: GDX ) and the Global X Silver Miners ETF (NYSE: SIL ). Keep an eye on the SPDR... Read More
from Latest Articles from Benzinga.com
First Trust AMEX Biotechnology Index Fund Has Returned 29.6% Since SmarTrend Recommendation (FBT)
May 09, 2013
from Comtex SmarTrend® News Briefs
Top News
More News
26.8% Return Seen to Date on SmarTrend First Trust AMEX Biotechnology Index Fund Call (FBT)
May 02, 2013
from Comtex SmarTrend® News Briefs
26.0% Return Seen to Date on SmarTrend First Trust AMEX Biotechnology Index Fund Call (FBT)
April 24, 2013
from Comtex SmarTrend® News Briefs
Vertex News Lifts Biotech ETFs
April 19, 2013
Shares of biotechnology firm Vertex Pharmaceuticals (NASDAQ: VRTX ) are soaring by more than 55 percent early Friday and have touched a new all-time high after the company announced late Thursday that... Read More
from Latest Articles from Benzinga.com
20.8% Return Seen to Date on SmarTrend First Trust AMEX Biotechnology Index Fund Call (FBT)
April 17, 2013
from Comtex SmarTrend® News Briefs
Under The Hood: An Unheralded Biotech ETF
April 11, 2013
Another day, another set of fresh all-time highs for the major biotechnology ETFs. Biotech investors were treated to the same feat in late March , but as health care has continued to be a... Read More
from Latest Articles from Benzinga.com
20.3% Return Seen to Date on SmarTrend First Trust AMEX Biotechnology Index Fund Call (FBT)
April 10, 2013
from Comtex SmarTrend® News Briefs
First Trust AMEX Biotechnology Index Fund Shares Up 23.0% Since SmarTrend's Buy Recommendation (FBT)
April 03, 2013
from Comtex SmarTrend® News Briefs
Biotech Breakout Boosting ETFs
March 28, 2013
The four horsemen of the biotechnology – Amgen (NASDAQ: AMGN ), Biogen Idec (NASDAQ: BIIB ), Celgene (NASDAQ: CELG ) and Gilead Sciences (NASDAQ: GILD ) – all hit new 52-week highs earlier Thursday.... Read More
from Latest Articles from Benzinga.com
Top Sector ETFs Ready for a Rest
March 22, 2013
The major averages have had a choppy week and may finish the week on a negative note as stocks were sharply lower again in Asia. This could be a positive for the stock market’s intermediate-term... Read More
from Forbes Real Time
First Trust AMEX Biotechnology Index Fund Up 19.2% Since SmarTrend Uptrend Call (FBT)
March 08, 2013
from Comtex SmarTrend® News Briefs
If Stocks Keep Soaring, Get to Know These Leveraged ETFs
March 08, 2013
Another day, another intrday record for the Dow Jones Industrial Average. Buoyed by a stronger-than-expected February jobs report, U.S. stocks continue to grind higher. Friday's action is of the... Read More
from Latest Articles from Benzinga.com
Daily ETF Folly: Why There Is No True Biotech Representation in ETFs
March 01, 2013
DailyFinance.com : 24/7 Wall St. is taking a daily aim at the world exchange-traded funds (ETFs). Many are great, and many are actively traded and truly represent what investors are trying to get... Read More
from DailyFinance.com
More M&A Deals Could Boost Biotech ETFs
December 11, 2012
As drug providers shift away from blockbuster drugs, the biotechnology sector, along with related exchange traded funds, will be supported by the next wave of specialized or targeted drugs. For... Read More
from ETF Trends

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here